
On Wednesday, the U.S. Department of Health and Human Services said that it would not renew a fetal tissue contract with the University of California, San Francisco and announced steps to limit future research using tissue from aborted fetuses. HHS also indicated that it is conducting a review to see if adequate alternatives exist for use of fetal tissue from abortions. This decision comes as a result of an HHS audit of human fetal tissue acquisitions that began in September.
Archbishop Joseph F. Naumann, Chairman of the U.S. Conference of Catholic Bishops' (USCCB) Committee on Pro-Life Activities praised the move in a statement. "We strongly commend the Trump Administration for taking actions to move our tax dollars away from research using body parts from aborted babies and toward ethical alternatives."
Archbishop Naumann's full statement can be found on the USCCB website.